CA
NZ
UK
AU
IND
US
For years, investors grappled with the looming shadow of Humira'sPatentexpiry and the subsequent rise of biosimil competition. This existential narrative cast a pall over AbbVie Inc. (NYSE: ABBV), suppressing its valuation multiples despite a strong track record. However, recent performance data, including a 12% …
Ken Fisher, a seasoned investor managing a portfolio worth $275 billion, has placed his bets on Alphabet Inc. (Nasdaq: GOOGL) as a compellingInvestmentin the burgeoning AI sector. With a price-to-Earnings(P/E) ratio of 22x, Alphabet stands out as the cheapest option among hyperscale AI stocks, …
The AI infrastructure trade witnessed a significant inflection point with the announcement of Amazon's (Nasdaq: AMZN) multi-billion dollar fibre deal with Corning Incorporated (NYSE: GLW). This agreement signals a crucial shift: hyperscalers' spending on AI-driven connectivity is transitioning from opportunisticCapital Expenditureinto a phase of …
com, Inc. (Nasdaq: AMZN) as a cornerstone of his artificial intelligence investment strategy. This conviction is primarily anchored in the projected trajectory of Amazon Web Services (AWS), which Fisher anticipates will surpass $200 billion in annual revenue by 2028. The driving force behind this …
Apple Inc. (Nasdaq: AAPL) has embarked on a bold pivot towards artificial intelligence with the introduction of its revamped Siri. This new iteration features enhancements like summarization, priority notifications, and AI-driven photo editing, aiming to blend user privacy with advanced capabilities. However, early assessments …
As SpaceX prepares for its monumental IPO, anticipated to be valued at $1.77 trillion, the event introduces a criticalLiquidity Riskfor existing markets, particularly within the AI semiconductor sector. Institutional investors, eager for a piece of the SpaceX pie, must divest from their current holdings, …
The recent sharp decline of a competing GLP-1 drug developer, which saw its shares fall by 23% following adverse clinical data, serves as a significant validation for Eli Lilly and its established position in the weight-loss market. This event highlights that developing drugs for …
Broadcom (Nasdaq: AVGO) experienced a notable post-Earningsdip, a reaction to guidance that signalled a moderation in AI ASIC revenue growth. While still projecting high double-digit expansion, the outlook represents a deceleration from the triple-digit surges that had fuelled investor exuberance. This "good, but not …
The rise of agentic AI, systems capable of autonomously executing complex tasks without human intervention, represents a paradigm shift in enterprise software. As organizations increasinglyDemandsophisticated solutions that enhance productivity and efficiency, agentic AI is projected to generate over $300 billion in annual revenue by …
ForMarket Participants, coffee illustrates how commodities differ from equities. Pricing is not driven byEarningsorCash Flowbut by shifting expectations around supply, demand, weather conditions, and currency movements. The latest softness reflects this dynamic adjustment rather than a fundamental reassessment of long-term consumption trends.
Please wait processing your request...